A Noninterventional, Cross-Sectional Study to Assess Patient Prostate Cancer Treatment Preferences and Experiences in Europe
The high satisfaction rates, particularly among those receiving injections every 6 months, suggest that less-frequent injections may be more convenient and preferable for many patients. These insights can help to guide patient-centric care and treatment decisions in prostate cancer management.
Authors
- M. Henry-Szatkowski
- Patrick Cabri
- Giuseppe Fallara (ORCID: https://orcid.org/0000-0001-7872-2650)
- Mehmet Inceer (ORCID: https://orcid.org/0000-0002-2594-9760)
- Ana Maria Rodriguez-Leboeuf
- Valérie Perrot (ORCID: https://orcid.org/0000-0002-5541-728X)
- Matteo Ferro
- E Karim
- Emmanuelle Kaltenbach
Institutions
- Ipsen (France) (FR)
- Ipsen (United Kingdom) (GB)
- Instituto Químico Biológico (ES)
- IQVIA (France) (FR)
- European Institute of Oncology (IT)
Publication Details
- Journal
- Advances in Therapy
- Published
- 2025-03-19
- DOI
- https://doi.org/10.1007/s12325-025-03152-4
- Citations
- 1
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.52
Funders
- Ipsen